Endothelial cells as targets for tumor therapy.

Endothelial cells as targets for tumor therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Endothelial cells as targets for tumor therapy. Abstract Text:

Endothelial cells as targets for tumor therapy. Publishing Authors By Initials

For similar pathological conditions, signs and symptoms: pathologic processes: metaplasia: neovascularization, pathologic research abstracts see: pathological conditions, signs and symptoms: pathologic processes: metaplasia: neovascularization, pathologic research

PUBMED ID PMID:

MEDLINE DATE:

Endothelial cells as targets for tumor therapy. Journal Published:

PUBLICATION TYPE: Editorial

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

VOLUME: 22

Page Numbers: 185

Journal Abbreviation: J. Immunother.

ISSN: 1524-9557

DAY: 18

MONTH: May

YEAR: 1999

Endothelial cells as targets for tumor therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9706083

Endothelial cells as targets for tumor therapy. Keywords Mesh Terms:

KEYWORDS: Neovascularization, Pathologic

MESH TERMS: therapy

Chemical & Substance for Abstract: Endothelial cells as targets for tumor therapy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Endothelial cells as targets for tumor therapy.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Immunother

REFSOURCE: J Immunother. 1999 May;22(3):186-211

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Endothelial cells as targets for tumor therapy Related Publications

• Adenovirus infection enhances killing of melanoma cells by a mitotoxin.
• An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.
• CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
• Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
• Dynamics of cell interactions and communications during melanoma development.
• Endothelial cells as targets for tumor therapy.
• Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.
• Learning the ABCs of Melanoma-Initiating Cells.
• Life isn't flat: taking cancer biology to the next dimension.
• Melanoma and the tumor microenvironment.
• Melanoma stem cells: the dark seed of melanoma.
• Old disease, new culprit: tumor stem cells in cancer.
• Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
• Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy.
• Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
• Targeting the stromal fibroblasts: a novel approach to melanoma therapy.
• The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis.
• The many faces of Notch signaling in skin-derived cells.
• Unraveling the mysteries of IGF-1 signaling in melanoma.
• [1st successful immunization of pancreas and colorectal carcinoma patients with CO17-1A-vaccine]
• [Not Available.]
• [POSTOPERATIVE EFFECTS OF CESAREAN SECTION.]
• [Stability of Teschen, HCC, ND and vaccinia viruses against 5 disinfectants]